BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10585576)

  • 1. Role of MT-MMPs and MMP-2 in pancreatic cancer progression.
    Ellenrieder V; Alber B; Lacher U; Hendler SF; Menke A; Boeck W; Wagner M; Wilda M; Friess H; Büchler M; Adler G; Gress TM
    Int J Cancer; 2000 Jan; 85(1):14-20. PubMed ID: 10585576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
    Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
    Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells.
    Ohnishi Y; Tajima S; Ishibashi A
    Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
    Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
    Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
    Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
    Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mRNA for membrane-type 1, 2, and 3 matrix metalloproteinases in human laryngeal cancer.
    Sun YN; Li Y
    Chin Med Sci J; 2004 Sep; 19(3):170-3. PubMed ID: 15506641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
    Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
    J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
    Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
    Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
    Zhang J; Hampton AL; Nie G; Salamonsen LA
    Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.